Literature DB >> 356764

Indomethacin and naproxen suppositories in the treatment of rheumatoid arthritis.

H Berry, D Swinson, J Jones, E B Hamilton.   

Abstract

A double-blind cross-over study of 35 out-patients with rheumatoid arthritis showed that Naproxen and Indomethacin suppositories were both effective forms of treatment in rheumatoid arthritis, both being significantly superior to placebo in terms of relief of morning stiffness.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 356764      PMCID： PMC1000247          DOI： 10.1136/ard.37.4.370

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  2 in total

1.  Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

Authors:  D M Ritchie; J A Boyle; J M McInnes; M K Jasani; T G Dalakos; P Grieveson; W W Buchanan
Journal:  Q J Med       Date:  1968-07

2.  Four new anti-inflammatory drugs: responses and variations.

Authors:  E C Huskisson; D L Woolf; H W Balme; J Scott; S Franklin
Journal:  Br Med J       Date:  1976-05-01
  2 in total
  10 in total

1.  Suppositories for arthritis.

Authors:  J P Famaey
Journal:  Clin Rheumatol       Date:  1992-03       Impact factor: 2.980

2.  Matching the Drug to the Patient: The rational use of antiarthritic drugs.

Authors:  P Lee
Journal:  Can Fam Physician       Date:  1991-01       Impact factor: 3.275

Review 3.  NSAID-induced gastrointestinal damage. Epidemiology, risk and prevention, with an evaluation of the role of misoprostol. An Asia-Pacific perspective and consensus.

Authors:  G D Champion; P H Feng; T Azuma; D E Caughey; K H Chan; S Kashiwazaki; H C Liu; A R Nasution; M Nobunaga; S Prichanond; T P Torralba; V Udom; D Utis; S R Wang; W S Wong; D J Yang; M C Yoo
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

Review 4.  Prostaglandins and ulcerative colitis.

Authors:  D S Rampton; C J Hawkey
Journal:  Gut       Date:  1984-12       Impact factor: 23.059

Review 5.  Clinical pharmacokinetics of naproxen.

Authors:  N M Davies; K E Anderson
Journal:  Clin Pharmacokinet       Date:  1997-04       Impact factor: 6.447

6.  Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis.

Authors:  S Sedghi; J Z Fields; M Klamut; G Urban; M Durkin; D Winship; D Fretland; M Olyaee; A Keshavarzian
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

7.  Indomethacin in rheumatoid arthritis: comparison of oral and rectal dosing.

Authors:  N Baber; R Sibeon; E Laws; L Halliday; M Orme; T Littler
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

Review 8.  Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-10       Impact factor: 9.546

9.  Are prostaglandins cytoprotective in the human large intestine? The effect of indomethacin on rectal mucosal function and prostaglandin E2 release in vivo.

Authors:  D S Rampton; T P Barton
Journal:  Agents Actions       Date:  1984-06

Review 10.  Role of eicosanoids in human and experimental colitis.

Authors:  R Schumert; J Towner; R D Zipser
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.